Literature DB >> 10711853

Rationale for once-daily therapy in asthma: compliance issues.

M E Hyland1.   

Abstract

Compliance in asthma is known to be poor. Once-daily treatment provides an additional therapeutic option for the clinician whose treatment aims include maximising treatment satisfaction and compliance. Once-daily treatment is preferred by some but not all patients and may lead to greater compliance in patients who are concerned about the effect of corticosteroids on their health. When switching to once-daily treatment, patients should be given a choice as to the time of treatment to minimise the impact of forgetting a dose.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10711853     DOI: 10.2165/00003495-199958004-00001

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  15 in total

1.  Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials.

Authors:  E F Juniper; G H Guyatt; R S Epstein; P J Ferrie; R Jaeschke; T K Hiller
Journal:  Thorax       Date:  1992-02       Impact factor: 9.139

2.  A scale for assessing quality of life in adult asthma sufferers.

Authors:  M E Hyland; S Finnis; S H Irvine
Journal:  J Psychosom Res       Date:  1991       Impact factor: 3.006

3.  Problems of recall and misclassification with checklist methods of measuring stressful life events.

Authors:  K G Raphael; M Cloitre; B P Dohrenwend
Journal:  Health Psychol       Date:  1991       Impact factor: 4.267

4.  Compliance is not all.

Authors:  M Marinker
Journal:  BMJ       Date:  1998-01-10

5.  Compliance in clinical trials of two nonbronchodilator, antiasthma medications.

Authors:  H Mawhinney; S L Spector; R A Kinsman; S C Siegel; G S Rachelefsky; R M Katz; A S Rohr
Journal:  Ann Allergy       Date:  1991-04

6.  Adverse effects of inhaled budesonide (800 micrograms) on growth and collagen turnover in children with asthma: a double-blind comparison of once-daily versus twice-daily administration.

Authors:  C Heuck; O D Wolthers; G Kollerup; M Hansen; B Teisner
Journal:  J Pediatr       Date:  1998-11       Impact factor: 4.406

7.  Predicting patient attitudes to asthma medication.

Authors:  L M Osman; I T Russell; J A Friend; J S Legge; J G Douglas
Journal:  Thorax       Date:  1993-08       Impact factor: 9.139

8.  Objective measurements of compliance in asthma treatment.

Authors:  F Chmelik; A Doughty
Journal:  Ann Allergy       Date:  1994-12

9.  Compliance of patients with asthma with an experimental aerosolized medication: implications for controlled clinical trials.

Authors:  S L Spector; R Kinsman; H Mawhinney; S C Siegel; G S Rachelefsky; R M Katz; A S Rohr
Journal:  J Allergy Clin Immunol       Date:  1986-01       Impact factor: 10.793

10.  Patient compliance with inhaled medication: does combining beta-agonists with corticosteroids improve compliance?

Authors:  C M Bosley; D T Parry; G M Cochrane
Journal:  Eur Respir J       Date:  1994-03       Impact factor: 16.671

View more
  2 in total

Review 1.  Inhaled mometasone furoate: a review of its use in adults and adolescents with persistent asthma.

Authors:  M Sharpe; B Jarvis
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Medication non-adherence in the elderly: how big is the problem?

Authors:  Carmel M Hughes
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.